Connor, Clark & Lunn Investment Management Ltd. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$68,545
-41.7%
70,231
-37.9%
0.00%
-100.0%
Q4 2022$117,601
-23.6%
113,078
-15.4%
0.00%0.0%
Q3 2022$154,000
-6.7%
133,662
+51.0%
0.00%0.0%
Q2 2022$165,000
-63.8%
88,502
-41.2%
0.00%
-50.0%
Q1 2022$456,000
-53.6%
150,492
-42.0%
0.00%
-60.0%
Q4 2021$982,000
-23.5%
259,670
+4.6%
0.01%
-28.6%
Q3 2021$1,284,000248,3080.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders